Purpose: To determine if radiation treatment plans created based on autosegmented (AS) regionsof-interest (ROI)s are clinically equivalent to plans created based on manually segmented ROIs, where equivalence is evaluated using probabilistic dosimetric metrics and probabilistic biological endpoints for prostate IMRT. Method and materials: Manually drawn contours and autosegmented ROIs were created for 167 CT image sets acquired from 19 prostate patients. Autosegmentation was performed utilizing Pinnacle's Smart Probabilistic Image Contouring Engine. For each CT set, 78 Gy/39 fraction 7-beam IMRT treatment plans with 1 cm CTV-to-PTV margins were created for each of the three contour scenarios; P MD using manually delineated (MD) ROIs, P AS using autosegmented ROIs, and P AM using autosegmented organ-at-risks (OAR)s and the manually drawn target. For each plan, 1000 virtual treatment simulations with different systematic errors for each simulation and a different random error for each fraction were performed. The statistical probability of achieving dose-volume metrics (coverage probability (CP)), expectation values for normal tissue complication probability (NTCP), and tumor control probability (TCP) metrics for all possible cross-evaluation pairs of ROI types and planning scenarios were reported. In evaluation scenarios, the root mean square loss (RMSL) and maximum absolute loss (MAL) of coverage probability of dose-volume objectives, E[TCP], and E [NTCP] were compared with respect to the base plan created and evaluated with manually drawn contours. Results: Femoral head dose objectives were satisfied in all situations, as well as the maximum dose objectives for all ROIs. Bladder metrics were within the clinical coverage tolerances except D 35Gy for the autosegmented plan evaluated with the manual contours. Dosimetric indices for CTV and rectum could be highly compromised when the definition of the ROIs switched from manually delineated to autosegmented. Seventy-two percent of CT image sets satisfied the worst-case CP thresholds for all dosimetric objectives in all scenarios, the percentage dropped to 50% if biological indices were taken into account. Among evaluation scenarios, (MD,P AM ) bore the highest resemblance to (MD,P MD ) where 99% and 88% of cases met all CP thresholds for bladder and rectum, respectively. Conclusions: When including daily setup variations in prostate IMRT, the dose-volume metric CP, and biological indices of ROIs were approximately equivalent for the plans created based on manually drawn targets and autosegmented OARs in 88% of cases. The accuracy of autosegmented prostates and rectums are impediment to attain statistically equivalent plans created based on manually drawn ROIs.
INTRODUCTION
Region of interest (ROI) delineation is a crucial step in external beam radiation therapy planning. Errant ROIs can yield misguided deliveries with undesirable clinical consequences. Currently, ROIs are mostly segmented manually by physicians or dosimetrists prior to their use in treatment planning. While manual contouring is the clinical standard for structure delineation during treatment planning, it is both time consuming and prone to inter-and intraobserver contour variability. [1] [2] [3] [4] [5] To alleviate this bottleneck and to move toward fully automated treatment planning procedures, autocontouring techniques have been developed. 6, 7 In both manual and automated contouring processes, delineation uncertainties are inherent to the resulting contours. Intrinsic and extrinsic factors can limit the ability to delineate anatomical regions for different imaging modalities 1, 4, 8 due to poor soft tissue contrast, noise, and image artifacts. In addition, manual contours have interobserver 1 delineation variability (due to different perception of observers), and intraobserver 2,4,9 delineation variability (rooted in different interpretations/perception of the same observer in different trials). Observer variability is one of the dominant geometric uncertainties in radiation therapy, 10 nonetheless, manual contours are considered the gold standard. While similarity metrics between manual physician-contoured ROIs and autocontoured ROIs are progressively improving, 6 the similarity metric threshold or other contour adequacy measure required to safely employ autocontouring in radiation therapy procedures is unclear.
The required spatial accuracy of ROI delineation depends on several factors including treatment site, prescribed dose to target(s), relative distance to other ROIs, potential dosimetric and biological consequences, delivery technique, dose conformity, as well as the relative size of the contour uncertainty compared with other uncertainties such as underlying geometric setup uncertainties. With margins added to provide a buffer for some components of the uncertainties, it is not clear if an additional margin is needed to accommodate contouring uncertainties. If, or when, current margins or planning techniques sufficiently account for contour variability between manual and autocontouring algorithms, then the transition from the current gold standard (manually drawn ROIs) to autocontoured ROIs can occur without sacrificing plan quality.
This work is based on the premise that autocontoured ROIs are adequate when they result in treatment plans that are equivalent to those based on manually drawn ROIs. We consider equivalent radiation therapy plans as plans which should result in an equivalent outcome. The inference in current clinical planning is that plans with matching dose-volume histograms or equal critical dose-volume indices are equivalent. In planning studies, equivalence of outcome surrogates, such as normal tissue complication probability (NTCP) and tumor control probability (TCP), can be quantified to infer equivalence. However, these evaluations often neglect inherent variances and uncertainties between the planned treatment and that achieved for a patient. In particular, typical evaluations assume that the patient pose and position for each treatment is the same as the pose and position at the time of treatment planning simulation.
Consider various methods to evaluate plan equivalence to judge the clinical adequacy of autocontours for treatment planning. A simple method would be to compare static plan metrics, [11] [12] [13] for example, for a fixed plan (dose distribution) compare the DVH of PTV created by expanding an autocontoured clinical target volume (CTV) with respect to the DVH of the PTV generated from the manual-contoured CTV. This approach na€ ıvely ignores the fact that the purpose of a PTV/ PRV is to ensure that the underlying CTV/OAR receives/is spared from the critical dose after uncertainties are considered. An alternative is to utilize treatment delivery simulations to estimate the coverage probability (CP) of the dosevolume metrics of interest and compare them for the different plans. In this context, equivalent plans with respect to dosimetric objectives and biological endpoints are plans with equivalent CP for the dose-volume objectives and equivalent TCP, and NTCP distributions.
In this study, we evaluated the equivalency/similarity of treatment plans created using alternative contour sets by comparing the probability of a plan achieving meaningful dosimetric and biological endpoints. Treatment delivery simulations, which incorporate the dosimetric consequences inherent to daily setup errors, were used to evaluate the probabilities. For a patient population, we examined if plans created with autosegmented ROIs (P AS ) would likely achieve the same endpoints as if manually drawn ROIs were utilized for planning (P MD ). Due to the importance of accurately defining the target, in a third scenario, we also evaluated plans with autosegmented normal tissues and a manually drawn target (P AM ). The proposed method has the potential to identify ROI deviations in terms of variations in dosimetric and biological indices. Ultimately, this work can provide a method for intercomparing alternative ROI delineations and therefore to examine the clinical adequacy of autocontouring algorithms in light of other inherent variations which affect the achieved patient dose.
METHODS

2.
A. Treatment plan creation and coverage probability evaluation Figure 1 shows the workflow for this study. The left side of the flowchart describes the data preparation stage for the study. The process starts with 229 manually contoured fanbeam CT image sets acquired from 19 different prostate patients. Patient CT images were obtained from the Netherlands Cancer Institute. The CT image resolution was 0.94 9 0.94 9 3 mm 3 . Readers are referred to earlier published work [14] [15] [16] for further information on this patient cohort. All manually contoured ROIs were drawn and reviewed by a single physician. The Smart Probabilistic Image Contouring Engine (SPICE) 6 module of Pinnacle 3 treatment planning system (Philips Medical Systems, Fitchburg, WI, USA) was utilized to obtain autosegmented contours for prostate, bladder, rectum, and femoral heads. To assess autosegmented contours sufficiency in the full treatment planning context, we used the commonly used procedure to create and evaluate IMRT prostate treatment plans. The right side of Figure 1 illustrates the evaluation process for each image set. The process starts with three sets of ROIs for autoplanning, namely set MD with manually drawn ROIs, set AS with autosegmented ROIs and set AM with autosegmented normal tissues and a manually drawn target. A 1 cm fixed margin (isotropic expansion) was used to create planning target volume (PTV) from the clinical target volume to account for simulated geometric uncertainties. The margin roughly approximates the van Herk formula result with the uncertainties from Table I . Seven-beam IMRT treatment plans were generated for each ROI scenario (MD, AS, and AM), resulting in plans (P MD , P AS , and P AM ). A 78 Gy/39 fraction prescription was used. The beams were transversally distributed at gantry angles: 30°, 80°, 130°, 180°, 230°, 280°, 330°. The generated plans were created based on objectives in Table II for all patients. Direct machine parameter optimization (DMPO) from Pinnacle 3 (Research Version 9.710) was employed to optimize all plans, with a 333 mm 3 dose grid resolution, a maximum of 50 iterations, and a maximum of 50 segments.
Since SPICE does not autocontour the sigmoid, the manually drawn sigmoid was used in optimization of all plans. A script was used to automate the generation of P MD , P AS , and P AM to ensure uniform study execution across all plans, image sets, and patients.
As setup uncertainties are inherent to the treatment delivery process, instead of analyzing the alternative static plans, plans were analyzed including the effect of setup uncertainties via treatment delivery simulations. Robustness analysis of the generated plans was performed for a rigid body geometric uncertainty model with the parameters from Table I sampled as zero-mean Gaussian probability distribution functions (PDFs). 17 A similar type of plan robustness analysis has been carried out to compare static plans to those created using probabilistic treatment planning techniques. 13, 18 In this study, robustness analysis consisted of performing 1000 virtual treatment courses with different sampled systematic errors for each treatment course and a different sampled random error for each fraction. Proof that the 1000 simulations are adequate to achieve statistical significance is given in the supplemental material. We leveraged our in-house GPUaccelerated radiation therapy robustness analyzer to perform the simulations. The robustness analyzer directly samples random translational and rotational setup uncertainties inherent to multifractional external beam treatment delivery, 17 assuming the dose distribution is shift-invariant 15 and outputs DVHs and other treatment metrics for each virtual treatment course simulated. To estimate the CP for a specific DVH metric, a dose-volume coverage map (DVCM) 19 was employed (i.e., a map that expresses CP as a function of dose-volume level). Details of the coverage evaluation computation can be found in [19] [20] [21] [22] and in the supplemental information. The robustness analyzer reports the CP at each specified dosevolume objectives, as well as the expectation values and distributions of biological indices. The reader is referred to the supplemental material for information about the TCP and NTCP models.
For each contoured CT image set, for each of the three plans (P MD , P AS , P AM ), treatment delivery simulations were performed with respect to each manual (MD) and each autosegmented contour (AS), resulting in six evaluations of each objective shown in Table II . The syntax used for these evaluation is (evaluation contour, planning contour), for example, for (AS, P MD ), the plan was developed with the manually drawn contours and the evaluation was with respect to the autosegmented contours. For each objective, arrays of each evaluation were constructed by concatenating the results for all the CT image sets. In comparing the arrays, (MD, P MD ), was taken as the gold standard. 
Where v i ð Þ and u i ð Þ are the QM evaluated on the ith CT image set for the test (v) and reference standard (u) scenarios. In this paper, in the absence of uncertainty (initial/unperturbed plan), the QM could be a dose-volume objective, NTCP, or TCP. In the presence of uncertainties, the QM could be CP of a dose-volume objective, E[TCP] or E [NTCP] . By definition, decrease in CP of dose-volume objectives, TCP, E[TCP], minimum dosimetric objectives is considered to be loss, whereas for the remaining indices the degradation occurs when they increase. To incorporate these, the loss function L(.) is defined as Eq. (3) where H(.) is Heaviside function. Throughout the paper, D symbol indicates difference between v and u arrays for the QMs.
2.B. Clinical significance assessment
To determine clinically relevant ranges for the RMSL and MAL similarity metrics, a dose perturbation analysis was performed. The analysis investigated the effect of the daily linac output variations (OV)s on the CPs, E[NTCP], and E [TCP] in the presence of daily setup motion. The RMSL and MAL for equivalent plans should be less than or equal to that inherent to acceptable day-to-day linac OVs. 23 For the baseline (MD, P MD ) scenario, the probabilistic gain and loss of each index was calculated as a function of OV for all 229 prostate patients in this study. Figure 3 depicts the procedure for given CT image set, ROI, selected dosimetric objective, and OV factor of linac. Robustness analysis was performed for the perturbed dose (dose due to P MD multiplied by linac OV) to compute the perturbed CP values associated with objectives as well as the perturbed E[TCP] and E[NTCP] metrics. The perturbed indices were compared against the baseline counterparts to determine gain/loss in the worst case and similarity assessment metrics.
RESULTS
The SPICE autosegmentation generated of all required ROIs (prostate, bladder, rectum, femoral heads) for 167 CT image sets from 18 patients. For the remaining image sets, SPICE failed in accomplishing at least one requisite ROI. SPICE failed on all image sets for one patient (Patient 10). We did not observe any obvious distinction in these image sets that would result in the failure. These failed image sets were excluded from the remaining analysis. Table III summarizes the failures pattern in the cohort. While the CTV and rectum did not fail, the frequency of failure in autosegmentation of bladder was the highest followed by right and left femurs. The reader is referred to supplemental materials for more details on the segmentation quality.
FIG. 2.
After planning and evaluating CP of the desired objectives for all CT images sets, six different QM arrays are formed each corresponding to one scenario. Therefore, the similarity assessment process in essence is a matter of comparing the resultant probability arrays with respect to baseline scenario (MD, P MD ).
[Color figure can be viewed at wileyonlinelibrary.com]
3.A. Similarity assessment of dosimetric and biological indices in the absence of uncertainties
Before probabilistic assessment of the desired dosimetric and biological indices, the similarity assessment of the static evaluation of the QMs was investigated for the patient cohort in the absence of setup uncertainties. For static evaluations, PTV coverage is compared since corresponds with current clinical practice as the PTV is intended to accommodate variations. Figure 4 illustrates the variations of the dosimetric and biological QMs for the unperturbed plans in the different plan evaluation scenarios. Plan QM variability is the lowest in scenarios (MD, P MD ), (AS, P AS ), and (MD, P AM ), that is, evaluation scenarios in which the ROI definitions are not switched from manually drawn to autosegmented, and viceversa, particularly for the PTV. Variations in the other scenarios indicate the extent to which coverage could be affected by the alternative segmentations. Altering the PTV definition results in large variations in the PTV D 95 and TCP. This is expected as dose distributions are designed to tightly conform to the PTV used in planning. For OARs, the similarity between distributions is evident for many QMs in scenarios (MD, P MD ) and (AS, P AS ). Except for four CT image sets, bladder's dose-volume metrics are satisfied, and there are wide margins between the samples median and the optimization objectives in all scenarios. This is due to the inclusion of a low weight (10 À10 ) generalized equivalent uniform dose objective (gEUD = 0) in the optimization to lower OAR doses below the other specified objectives. The dosimetric QMs for autosegmented rectums are more dispersed than their manually drawn counterparts. Note that the increased variation in autosegmented rectum was not solely attributed to the difference in rectum contours, but the collective deviations in all autosegmented ROIs. To clarify this point, for instance, consider variations in D 50 for (AS, P AM ) which are closer to those of (MD, P MD ) evaluations, which indicates using MD CTV could partially alleviate the impact of the alternative autosegmented OARs.
The similarity between dosimetric and biological indices of individual structure set in the different scenarios with respect to initial/unperturbed plans are shown in Figs. 5, 6, and 7 for the PTV, bladder, and rectum, respectively. In these comparisons, deviations are given with respect to the baseline evaluation scenario (MD, P MD ). Dotted lines are used to subdivide the patients.
For the PTV, D max does not considerably change across all evaluation scenarios. The dose-volume metrics and TCPs in (AS, P AS ) and (MD, P AM ) are close to their corresponding values in (MD, P MD ), whereas for (MD, P AS ), (AS, P MD ), and (AS, P AM ), they are compromised for some CT image sets. This emphasizes the importance of the definition of the target.
For OARs, positive values imply degradation in indices. In Fig. 6 , dosimetric indices have RMSL> 4.51 and MAL> 27.73 for bladder in all the scenarios except (MD, P AM ). However, as shown in Fig. 4 , these deviations do not result in objective violation except for a small number of CT image sets due to the wide gap between the dose metrics and the objective thresholds. Similarly, rectum's dose-volume indices have large MALs and RMSLs in all the evaluation scenarios except for (MD, P AM ) (Fig. 7) . The dissimilarities between metrics are more evident for D 50 . 
3.B. Similarity assessment of dosimetric and biological indices in the presence of uncertainties
The 167 image sets successfully autocontoured were subject to planning with the drawn, autosegmented, and mixed contour sets, then had coverage probabilities assessed for each dose-volume objective as well as expectation values of the TCP and NTCP based on manual contours. In at least 96% of CT image sets, the probability of achieving all the dose-volume objectives for a given plan was greater than 0.9, independent of the contours used for evaluation. Figure 8 illustrates the difference between the expectation value of the NTCP and the CPs for the bladder subject to the different evaluation scenarios in comparison with the baseline scenario (MD, P MD ). Note, only negative DCP values indicate degraded plan quality. In most cases (83%), |DCP|< 0.02. For 69% of cases, DCP> = 0. The remaining 31% have DCP< 0 and are poorer plans which contribute to RMSL and MAL. RMSL values indicate strong resemblance between probability arrays (RMSL≤ 0.037).
For three of the four bladder metrics analyzed the MAL and RMSL values are less for (MD, P M ) than for (MD, P AS ) indicating the importance and dependence on manual target contouring. Interestingly, while E[NTCP] is poorer for (AS, P AM ) than for (MD, P AM ), the MAL and RMSL for all of the dose-volume objectives is lower for (AS, P AM ). In scenario (MD, P AM ), the worst-case DCP for D 25 had MAL equal to 0.263. Note that E[NTCP] has the least variation (RMSL = 0.008, MAL = 0.042) in scenario (MD,P AM ). The maximum E[NTCP] loss occurred in evaluation scenario (AS,P AS ). Figure 9 shows the differences between the E[NTCP] and dose-volume objective CPs for the rectum for each scenario compared with the baseline. In contrast to bladder results, the distributions have larger standard deviations in Figure 10 illustrates the DCP for the CTV's D min and D 95 objectives. Visually, there appears to be two groupings: {(MD,P AM ), (AS, P AS )} and {(AS, P MD ), (MD,P AS ), (AS,P AM )}, those in which the assessment CTV and plan CTV are the same, and those in which they differ. Comparing D 95 DCP for (MD, P AM ) and (AS, P AS ) to (MD, P D ), RMSLs of 0.008 and 0.009, respectively, are found, indicating strong similarity between the arrays. Moreover, the CP for D 95 is greater than 0.9 for 99.28% of the cases. On the other hand, the RMSL values for (AS,P MD ), (MD,P AS ), and (AS,P AM ) are 0.584, 0.19, and 0.451, respectively, indicating much less similarity between the CPs. The RMSL values for D min also differ from {(MD, P AM ), (AS,P AS )} to {(AS,P MD ), (MD,P AS ), (AS,P AM )} scenarios. RMSLs for (MD,P AM ), (AS,P AS ) are 0.131 and 0.157, which again implies high degree of similarity with the (MD,P MD ) scenario. RMSL values for scenarios (AS, P MD ), (MD,P AS ), and (AS,P AM ) are 0.73, 0.55, and 0.70, respectively, which indicates that CPs are far from the base scenario. Similarly, DE[TCP] for different scenarios follow the same pattern. While MAL < 0.021 for {(MD, P AM ), (AS,P AS )}, MAL is at least 0.076 for {(AS,P MD ), (MD,P AS ), (AS,P AM )} scenarios. for D min and D 95 goals, there are evident differences between scenarios that a contour is evaluated on the plan created based on the same contour {(MD,P AM ), (AS,P AS )} and the remaining ones {(AS, P MD ), (MD, P AS ), (AS,P AM )}.
3.B.1. Clinical significance assessment
To estimate de facto current clinically accepted variations in CPs, the CP arrays are calculated for (MD, P MD ) for all different 299 CT image sets as a function of permissible linac day-to-day OVs. The worst-case clinical scenario was used for the simulations, a systematic offset of the output for all treatment fractions. Figure 11 illustrates gain and loss of both maximum absolute and root mean square for all the dosimetric and biological indices as output varied from À10% to 10%. Note that some indices were more sensitive to the changes in output. For instance, the CP of CTV D min and D 95 change abruptly with a small OV compared to the other metrics. As AAPM TG142 23 recommends that linac OVs be less than AE 2% daily for treatment machines delivering IMRT, the CP variation inherent to this level of variation is taken as the clinically relevant tolerance. Table IV compares the RMSL values of dosimetric indices from the different contour plan/evaluation scenarios to their corresponding thresholds obtained from dose perturbation simulations.
Metrics for the bladder were in tolerance for all scenarios except D 35 for (MD, P AS ), which corresponds to 2.1% change in linac output. For each dosimetric index, the scenario that did not meet its corresponding threshold is highlighted. The numbers in the parentheses are the linac output values corresponding to the observed RMSL in percent. All CTV and all rectal metrics (except D max ) for (AS,P MD ) À (MD,P MD ) exceeded the calculated clinically relevant thresholds, indicating the inadequacy of autotarget contouring.
For planning scenario P AM , the metrics for bladder and CTV were less than the thresholds disregarding ROI type. However, rectum's metrics failed to meet the CP thresholds except for (MD,P AM ). Table V reports the fraction of the CT image sets that fall below the OV-based thresholds for MAL. More than 98% of the cases met MAL threshold for dose-volume objectives of the bladder. The lowest fraction occurred for D 20 of rectum in (MD,P AS ) for which 83% of the cases met MAL threshold. The fractions of the cases meeting MAL threshold of E [NTCP] for bladder and rectum were within AE 0.02 across all the evaluation scenarios. For bladder, more than 99% of the cases fell below MAL thresholds in (MD, P M ) scenario. All the cases satisfied MAL threshold for CTV which implies that the OV effect to MAL for indices of CTV was dominant compared to the effect of delineation uncertainty due to autosegmentation to the same metric.
Considering all the metric and evaluation scenarios, 72% of CT image sets satisfied the clinically relevant threshold for MAL for CP of all dosimetric objectives and all scenarios. Only 50% of the cases satisfy the threshold for all the biological and dosimetric indices. If the thresholds are set to CP values corresponding to AE 1% output variation, then 64% of cases satisfied all the dosimetric worst-case scenario thresholds, and 25% of cases met both biological and dosimetric indices thresholds. By increasing the CP threshold level to AE 10% OV, around 97.2% of CT image sets satisfy the CP thresholds in scenarios. This means that in 2.8% of the cases, the CP loss due to DU of autosegmentation remains dominant compared to CP losses caused by such a large OV. The results implied that manual and autosegmented ROIs cannot be interchangeably used in all the scenarios.
Considering only (MD,P AM ) scenario, 99.41% and 88.02% of cases met bladder and rectum's CP thresholds, respectively. The worst-case threshold was limited by rectum since all the 88% passing cases meet CTV and bladder metrics.
DISCUSSION
Delineation uncertainty is considered a major contributor to geometric uncertainties in radiotherapy. Nonetheless, radiotherapy has enjoyed current success even though explicit margins are not added to accommodate inter-or intraobserver contour variations. Due to the variability in manually drawn contours and the effort required to create them, computer generated autocontours with sufficient accuracy for clinical use have been a long-sought-after goal. 6, 7, 24, 25 One barrier to reaching this goal is clarity as to what qualifies as sufficient accuracy or similarity between two alternative contours. The fact that intra-and interobserver variations are inherent to all manual segmentations, and such segmentations are considered acceptable implies that some level of variation is acceptable. Therefore, some deviation between autocontours and manual contours must also be acceptable. Numerous authors have investigated differences between autosegmented and manually drawn contours, 6, 7, 24, 25 mainly investigating the accuracy through comparison of contourbased similarity coefficients. These similarity analyses are intended to reveal how the autosegmented ROIs compared with the manual gold standard, however, they do not assess the adequacy of the autosegmented ROIs for the radiation therapy treatment. Dice similarity coefficient (DSC) is one of the most commonly used metrics to assess the quality of segmented ROIs. However, DSC lacks the spatial information, and therefore infinitely many configurations with different dosimetric outcomes could result in the same DSC. In this paper, the authors' intention was to analyze autosegmentation algorithm based on dosimetric and biological metrics without considering any other shape similarity metrics. For reference, DSC analysis is in the supplemental material.
A confounding aspect in evaluating ROI and plan equivalence is that clinical treatment plans are created based on expanded version of contoured ROIs, that is, a CTV is expanded to a PTV, and ideally, OARs to planning organ at risk volumes (PRVs). As such, one might consider the overlap of the margin-expanded manual and autosegmented ROIs in an equivalence assessment, but this too ignores clinical adequacy.
With the combined knowledge that (a) the purpose of safety margins is to ensure coverage/sparing of the underlying CTV/OAR when uncertainties are considered and (b) that the actual coverage/sparing is dictated by the conformity of the dose distribution, 18, 26, 27 we directly assess the CP via treatment delivery simulations. There is a strong precedent for use of simulations to assess CP 16, 18, 20, 21, 28, 29 and the often cited margin formulas by van Herk 17 and Stroom 30, 31 are based on treatment delivery simulations and population-based CP estimates. To account for the patient-/contour-specific plan and resulting dose distribution, we evaluate CP on a per-patient/ contour set basis. While our CP estimates account for rigid body motions, 19 our method can be extended to include the effects of organ deformations, 16 delineation uncertainties, 10 and other inherent uncertainties. Inclusion of further uncertainties will likely reduce the CP deviations between the planning/evaluation scenarios. In terms of our specific evaluation to prostate autocontouring, (MD, P AS ) revealed that plans developed with SPICE autocontoured contours, but evaluated with manually drawn contours, yielded coverage estimates that differed from the manual-plan standard by a clinically significant amount. TCP distributions had lower mean values and higher dispersion when the P AS plan was used, in line with the statistical similarity assessment of dose-volume objectives. With the CTV being the prostate, this result is not surprising, as the CTV definition is critical to successful radiation therapy. 8, 32, 33 Similarity assessment of dose-volume objectives, CPs, and analyses in clinical significance assessment emphasize the need for improved autosegmentation of the rectum. This is due to the proximity of the rectum to the CTV and overlap with the PTV. The use of injected hydrogel buffer zones 34 between the prostate and rectum could mitigate this need.
Concentrating only on the P M plans with manual target contours but autocontoured OARs, the bladder DCP's within the output variation-derived CP tolerance. Specifically, for scenario (MD, P MD ), 99% of cases met bladder CP tolerance, and 95% of cases have expectation value of NTCP less than the MAL tolerance. Femur probabilistic objectives were met disregarding the scenario.
The advancement of autocontouring techniques in RT has the potential to result in more reliable contour sets with less delineation uncertainties. The probabilistic biological and dosimetric consequences can be evaluated in the proposed framework. It is likely that manual to autocontour and coverage similarity will continue to improve as autosegmentation algorithms evolve and improve. Nonetheless, ROI quality assurance, particularly to prevent use of obtuse contours remains necessary. Combination of knowledge-based and shape analysis techniques 35 may play an important role in this regard in the future.
A potential bias of this study is the limiting the analysis to cases in which SPICE successfully autocontoured all of the required ROIs. Inclusion of partial SPICE successes (some, but not all required contours autosegmented) would have overly confused the study. However, as SPICE independently contours each ROI, substitution of manual ROIs for failed autosegmented ROIs is not expected to alter the suitability of the successfully generated auto-OAR ROIs.
One should be cautioned that our specific study results are dependent on our planning method and the prostate treatment site. Alternative planning methods with altered conformity could impact the findings. However, alternative planning methods are currently clinically used even though inherent inter-and intraobserver variability exists, without apparent coverage concerns. Nonetheless, the proposed approach is general and can be applied to any combinations of segmentations (manual or auto), treatment site, planning technique, and arbitrary probabilistic uncertainty model. This opens up possibilities to evaluate the effect of ROI delineation errors in combination with other aspects involved in treatment plan creation.
CONCLUSION
In this work, we measured autocontouring adequacy in terms of clinical equivalence as measured by coverage probability assessed by treatment delivery simulations. By assessing CP of objectives with alternative underlying ROIs, we evaluated the plan evaluation metric equivalence to the alternative ROIs. Our method provides a systematic way to assess the similarity between two contour sets with respect to probabilistic dosimetric indices and biological endpoints. The dosimetric similarity with respect to a metric was measured by estimating the similarity arrays between probabilities of meeting the desired metric. The method was used to assess the adequacy of SPICE-generated contours by comparing the CP for prostate IMRT plans based off of manual and autosegmented ROIs. The analyses revealed that in order to statistically achieve clinically relevant tolerance for dosimetric and biological indices, the SPICE's current accuracy of delineating prostate, and rectum needs to be improved.
